Teleflex Inc. (TFX) saw its shares soar by over 5% on November 1, 2024, despite reporting mixed results for the third quarter of 2024. While the medical device company missed revenue expectations, it delivered better-than-anticipated earnings per share (EPS) and raised its full-year EPS guidance, fueling investor optimism.
The company posted Q3 2024 adjusted EPS of $3.49, surpassing the consensus estimate by 3.3%. However, net revenues of $764.4 million fell slightly short of analyst projections, increasing by 2.4% year-over-year but missing the mark by 0.4%.
Despite the revenue miss, Teleflex's strong earnings performance and positive outlook for the year appear to have driven the stock's significant gain. The company raised its 2024 adjusted EPS guidance range to $13.90-$14.20, reflecting growth of 2.8% to 5% compared to the previous year.
Comments